4.4 Article

Hepatocyte growth factor promotes migration of human myeloma cells

期刊

HAEMATOLOGICA
卷 93, 期 4, 页码 619-622

出版社

FERRATA STORTI FOUNDATION
DOI: 10.3324/haematol.11867

关键词

myeloma; cell migration; hepatocyte growth factor; stromal cell-derived growth factor-1

资金

  1. Norwegian Cancer Society
  2. Cancer Fund of St.Olavs Hospital, Familien Blix' fond, Rakel og Otto Kr. Bruuns legat
  3. Research Council of Norway

向作者/读者索取更多资源

Multiple myeloma is characterized by the accumulation and dissemination of malignant plasma cells in the bone marrow. Cell migration is thought to be important for these events. We studied migration in a Transwell two-chamber assay and tested the motogenic effect of various cytokines. In addition to insulin-like growth factor-1 and stromal cell-derived growth factor-1 alpha, previously known as chemoattractants for myeloma cells, we identified hepatocyte growth factor as a potent attractant for myeloma cells. Hepatocyte growth factor-mediated migration was dependent on phosphatidylinositol-3-kinase, involved the MAPK/Erk signaling cascade and VLA-4 integrins, but did not involve Akt, mTOR or G proteins.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Health Care Sciences & Services

Strategies parents use to give children oral medicine: a qualitative study of online discussion forums

Elin Hoien Bergene, Torstein Baade Ro, Aslak Steinsbekk

SCANDINAVIAN JOURNAL OF PRIMARY HEALTH CARE (2017)

Article Hematology

Lymphoma and myeloma cells are highly sensitive to growth arrest and apoptosis induced by artesunate

Toril Holien, Oddrun E. Olsen, Kristine Misund, Hanne Hella, Anders Waage, Torstein B. Ro, Anders Sundan

EUROPEAN JOURNAL OF HAEMATOLOGY (2013)

Article Hematology

Decorin is down-regulated in multiple myeloma and MGUS bone marrow plasma and inhibits HGF-induced myeloma plasma cell viability and migration

Ida B. Kristensen, Lise Pedersen, Torstein B. Ro, Jacob H. Christensen, Maria B. Lyng, Lars M. Rasmussen, Henrik J. Ditzel, Magne Borset, Niels Abildgaard

EUROPEAN JOURNAL OF HAEMATOLOGY (2013)

Article Hematology

Anti-c-MET Nanobody® - a new potential drug in multiple myeloma treatment

Tobias Schmidt Slordahl, Tinneke Denayer, Siv Helen Moen, Therese Standal, Magne Borset, Cedric Ververken, Torstein Baade Ro

EUROPEAN JOURNAL OF HAEMATOLOGY (2013)

Article Hematology

HGF and IGF-1 synergize with SDF-1α in promoting migration of myeloma cells by cooperative activation of p21-activated kinase

Torstein Baade Ro, Toril Holien, Unn-Merete Fagerli, Hakon Hov, Kristine Misund, Anders Waage, Anders Sundan, Randi Utne Holt, Magne Borset

EXPERIMENTAL HEMATOLOGY (2013)

Article Cell Biology

Immunohistochemical analysis of hepatocyte growth factor and c-Met in plasma cell disease

Karin F. Wader, Unn-Merete Fagerli, Magne Borset, Stian Lydersen, Hakon Hov, Anders Sundan, Anna Bofin, Anders Waage

HISTOPATHOLOGY (2012)

Article Oncology

Bone morphogenetic proteins induce apoptosis in multiple myeloma cells by Smad-dependent repression of MYC

T. Holien, T. K. Vatsveen, H. Hella, C. Rampa, G. Brede, L. A. G. Groseth, M. Rekvig, M. Borset, T. Standal, A. Waage, A. Sundan

LEUKEMIA (2012)

Article Multidisciplinary Sciences

Targeting Proliferating Cell Nuclear Antigen and Its Protein Interactions Induces Apoptosis in Multiple Myeloma Cells

Rebekka Mueller, Kristine Misund, Toril Holien, Siri Bachke, Karin M. Gilljam, Thea K. Vatsveen, Torstein B. Ro, Emanuele Bellacchio, Anders Sundan, Marit Otterlei

PLOS ONE (2013)

Article Oncology

Bone morphogenetic protein-9 suppresses growth of myeloma cells by signaling through ALK2 but is inhibited by endoglin

O. E. Olsen, K. F. Wader, K. Misund, T. K. Vatsveen, T. B. Ro, A. K. Mylin, I. Turesson, B. F. Stordal, S. H. Moen, T. Standal, A. Waage, A. Sundan, T. Holien

BLOOD CANCER JOURNAL (2014)

Article Oncology

Analysis of Intra-Tumoral Macrophages and T Cells in Non-Small Cell Lung Cancer (NSCLC) Indicates a Role for Immune Checkpoint and CD200-CD200R Interactions

Anders Tondell, Yashwanth Subbannayya, Sissel Gyrid Freim Wahl, Arnar Flatberg, Sveinung Sorhaug, Magne Borset, Markus Haug

Summary: The study identified two novel immunosuppressive pathways that may dampen the anti-tumor T cell immune response in lung cancer, emphasizing the importance of tumor-associated macrophages as a promising target for immunotherapy. Non-small cell lung carcinoma (NSCLC) commonly shows beneficial responses to immunotherapy with immune checkpoint inhibitors, but only in a proportion of patients. Identification of novel immunosuppressive pathways in NSCLC-associated immune cells is crucial for improving immunotherapy in NSCLC.

CANCERS (2021)

Article Biochemistry & Molecular Biology

Inhibition of Cytosolic Phospholipase A2α Induces Apoptosis in Multiple Myeloma Cells

Nur Mahammad, Felicity J. Ashcroft, Astrid J. Feuerherm, Samah Elsaadi, Esten N. Vandsemb, Magne Borset, Berit Johansen

Summary: The study demonstrates that cytosolic phospholipase A2 alpha (cPLA2 alpha) is overexpressed in certain hematological malignancies, including multiple myeloma, and inhibition of this enzyme significantly reduces cell viability and induces apoptosis. This implicates cPLA2 alpha as a potential target for treating hematological cancers such as multiple myeloma.

MOLECULES (2021)

Article Hematology

Highly expressed genes in multiple myeloma cells - what can they tell us about the disease?

Magne Borset, Samah Elsaadi, Esten N. Vandsemb, Eli Svorkdal Hess, Ida J. Steiro, Miguel Cocera Fernandez, Anne-Marit Sponaas, Pegah Abdollahi

Summary: The study investigates how cancer cells can convert proto-oncoproteins into oncoproteins without mutations by increasing gene expression. Through analyzing highly expressed genes in cancer cells from multiple myeloma patients, potential key players in the disease pathogenesis were identified, providing a guide for future studies aiming at promising treatment targets.

EUROPEAN JOURNAL OF HAEMATOLOGY (2022)

暂无数据